It’s been a tough year for investors in cannabis stocks, and in the broad market as well, as all major indexes are in downtrends.
Yet prospects for the cannabis industry remain bright, as state-by-state legalization trends continue.
But until trends turn up, there’s no urgency to buy, so our portfolio sits roughly half in cash, waiting for the upturn.
Full details in the issue.
Yours for wealth and wisdom.